BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15134782)

  • 1. The regulation of lymphocyte activation by inhibitory receptors.
    Leibson PJ
    Curr Opin Immunol; 2004 Jun; 16(3):328-36. PubMed ID: 15134782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands.
    Solana R; Casado JG; Delgado E; DelaRosa O; Marín J; Durán E; Pawelec G; Tarazona R
    Cancer Immunol Immunother; 2007 Jan; 56(1):101-9. PubMed ID: 16485126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
    Zhang C; Zhang J; Wei H; Tian Z
    Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.
    Bottino C; Moretta L; Pende D; Vitale M; Moretta A
    Mol Immunol; 2004 Jul; 41(6-7):569-75. PubMed ID: 15219995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.
    Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
    Immunol Lett; 2005 Aug; 100(1):7-13. PubMed ID: 16109445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
    Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of natural killer cells: underlying molecular mechanisms revealed.
    Backström E; Kristensson K; Ljunggren HG
    Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HLA class I-specific inhibitory receptors by chronically activated cytolytic T lymphocytes: useful or harmful to the host?
    Mingari MC; Ponte M; Vitale C; Schiavetti F; Bertone S; Moretta L
    Melanoma Res; 1997 Aug; 7 Suppl 2():S89-93. PubMed ID: 9578422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD107a as a functional marker for the identification of natural killer cell activity.
    Alter G; Malenfant JM; Altfeld M
    J Immunol Methods; 2004 Nov; 294(1-2):15-22. PubMed ID: 15604012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-tolerance of natural killer cells.
    Raulet DH; Vance RE
    Nat Rev Immunol; 2006 Jul; 6(7):520-31. PubMed ID: 16799471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes.
    Upshaw JL; Leibson PJ
    Semin Immunol; 2006 Jun; 18(3):167-75. PubMed ID: 16723257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.
    Tassi I; Klesney-Tait J; Colonna M
    Immunol Rev; 2006 Dec; 214():92-105. PubMed ID: 17100878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y; Starke A; Wüthrich RP
    Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells.
    Otsuki N; Kamimura Y; Hashiguchi M; Azuma M
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1121-7. PubMed ID: 16643847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
    Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
    Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CD160 binding to HVEM triggers an inhibitory signal to the activated T cell].
    Bensussan A
    Med Sci (Paris); 2008 Apr; 24(4):361-2. PubMed ID: 18405629
    [No Abstract]   [Full Text] [Related]  

  • 18. Multi-chain immune recognition receptors: spatial organization and signal transduction.
    Sigalov A
    Semin Immunol; 2005 Feb; 17(1):51-64. PubMed ID: 15582488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New insights into cytotoxic effector cells].
    Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
    Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
    Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
    Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.